265 related articles for article (PubMed ID: 29549157)
21. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
22. Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA.
Ametovski A; Macdonald C; Manning JJ; Haneef SAS; Santiago M; Martin L; Sparkes E; Reckers A; Gerona RR; Connor M; Glass M; Banister SD
ACS Chem Neurosci; 2020 Nov; 11(21):3672-3682. PubMed ID: 33054155
[TBL] [Abstract][Full Text] [Related]
23. Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid Receptors.
Gamage TF; Farquhar CE; McKinnie RJ; Kevin RC; McGregor IS; Trudell ML; Wiley JL; Thomas BF
J Pharmacol Exp Ther; 2019 Mar; 368(3):414-422. PubMed ID: 30552295
[TBL] [Abstract][Full Text] [Related]
24. Do you feel it now? Route of administration and Δ
Wiley JL; Lefever TW; Glass M; Thomas BF
Neurotoxicology; 2019 Jul; 73():161-167. PubMed ID: 30953678
[TBL] [Abstract][Full Text] [Related]
25. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
[TBL] [Abstract][Full Text] [Related]
26. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays.
Grafinger KE; Vandeputte MM; Cannaert A; Ametovski A; Sparkes E; Cairns E; Juchli PO; Haschimi B; Pulver B; Banister SD; Stove CP; Auwärter V
Drug Test Anal; 2021 Jul; 13(7):1412-1429. PubMed ID: 33908179
[TBL] [Abstract][Full Text] [Related]
27. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
[TBL] [Abstract][Full Text] [Related]
28. Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors.
Noble C; Cannaert A; Linnet K; Stove CP
Drug Test Anal; 2019 Mar; 11(3):501-511. PubMed ID: 30280499
[TBL] [Abstract][Full Text] [Related]
29. Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA.
Finlay DB; Manning JJ; Ibsen MS; Macdonald CE; Patel M; Javitch JA; Banister SD; Glass M
ACS Chem Neurosci; 2019 Oct; 10(10):4350-4360. PubMed ID: 31513380
[TBL] [Abstract][Full Text] [Related]
30. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA.
Haschimi B; Grafinger KE; Pulver B; Psychou E; Halter S; Huppertz LM; Westphal F; Pütz M; Auwärter V
Drug Test Anal; 2021 Aug; 13(8):1499-1515. PubMed ID: 33788409
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.
Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M
Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526
[TBL] [Abstract][Full Text] [Related]
32. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.
Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF
Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898
[TBL] [Abstract][Full Text] [Related]
33. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
[TBL] [Abstract][Full Text] [Related]
35. Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11.
Kevin RC; Cairns EA; Boyd R; Arnold JC; Bowen MT; McGregor IS; Banister SD
Front Psychiatry; 2022; 13():1048836. PubMed ID: 36590635
[TBL] [Abstract][Full Text] [Related]
36. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.
Kevin RC; Wood KE; Stuart J; Mitchell AJ; Moir M; Banister SD; Kassiou M; McGregor IS
J Psychopharmacol; 2017 Jun; 31(6):757-769. PubMed ID: 28093016
[TBL] [Abstract][Full Text] [Related]
37. Functional effects of synthetic cannabinoids versus Δ
Schreiber S; Bader M; Lenchinski T; Meningher I; Rubovitch V; Katz Y; Cohen E; Gabet Y; Rotenberg M; Wolf EU; Pick CG
Addict Biol; 2019 May; 24(3):414-425. PubMed ID: 29423994
[TBL] [Abstract][Full Text] [Related]
38. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA.
Janssens LK; Ametovski A; Sparkes E; Boyd R; Lai F; Maloney CJ; Rhook D; Gerona RR; Connolly M; Liu H; Hibbs DE; Cairns EA; Banister SD; Stove CP
ACS Chem Neurosci; 2023 Jan; 14(1):35-52. PubMed ID: 36530139
[TBL] [Abstract][Full Text] [Related]
40. Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.
Thomas BF; Lefever TW; Cortes RA; Grabenauer M; Kovach AL; Cox AO; Patel PR; Pollard GT; Marusich JA; Kevin RC; Gamage TF; Wiley JL
J Pharmacol Exp Ther; 2017 Apr; 361(1):162-171. PubMed ID: 28087785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
